Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Aug 1.

Published in final edited form as: J Stroke Cerebrovasc Dis. 2019 May 29;28(8):2255–2261. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.009

Figure 1. — A and B. Intravenous Thrombolysis Use Among Hospitalizations for Ischemic Stroke in the National Inpatient Sample, 1998–2015.

A. Annual rates of intravenous thrombolysis use among hospitalizations for acute ischemic stroke in the National Inpatient Sample from 1998–2015. Data is stratified by the presence of comorbid cancer. The lighter shade sections of the curves denote 95% confidence intervals.

B. Annual rates of intravenous thrombolysis use among hospitalizations for acute ischemic stroke in patients with cancer in the National Inpatient Sample from 1998–2015. Data is stratified by cancer type, including patients with non-metastatic hematologic cancers, non-metastatic solid cancers, and metastatic hematologic or solid cancers.

Figure 1. — A and B. Intravenous Thrombolysis Use Among Hospitalizations for Ischemic Stroke in the National Inpatient Sample, 1998–2015.

A. Annual rates of intravenous thrombolysis use among hospitalizations for acute ischemic stroke in the National Inpatient Sample from 1998–2015. Data is stratified by the presence of comorbid cancer. The lighter shade sections of the curves denote 95% confidence intervals.

B. Annual rates of intravenous thrombolysis use among hospitalizations for acute ischemic stroke in patients with cancer in the National Inpatient Sample from 1998–2015. Data is stratified by cancer type, including patients with non-metastatic hematologic cancers, non-metastatic solid cancers, and metastatic hematologic or solid cancers.